Stakeholders Argue Over Deadline For Marking Of Reprocessed Devices

Senators Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.) say FDA is misinterpreting deadlines for recently enacted device marking provisions

More from Archive

More from Medtech Insight